Trial ID or NCT#



not recruiting iconNOT RECRUITING


This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States. One hundred fifty (150) subjects diagnosed with gastroparesis, who satisfy the selection criteria for the study, will be randomized to one of two treatment groups, active or placebo.

Official Title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Efficacy of VLY-686 (Tradipitant) in Relieving Symptoms of Gastroparesis

Eligibility Criteria

Ages Eligible for Study: 18 Years to 70 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Linda Nguyen
Linda Nguyen
Gastroenterologist, Motility specialist
Clinical Professor, Medicine - Gastroenterology & Hepatology

Contact us to find out if this trial is right for you.


Emerald Poon Adler
(650) 721-2665